Aytu Biopharma, Inc Liquidation Value

AYTU Other

Cash & Equivalents

$30.02M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $30.02M
Total Obligations: -$76.73M
$-46.71M
Per share: $-4.35
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $30.02M
AR: $30.92M
Total Obligations: -$76.73M
$-15.78M
Per share: $-1.47
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $30.02M
AR: $30.92M
Inventory: $8.66M
Total Obligations: -$76.73M
$-7.13M
Per share: $-0.66
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-46.71M$-4.35
Liquid Liquidation Value$-15.78M$-1.47
Operating Liquidation Value$-7.13M$-0.66

Key Components (as of 2025-12-31)

Cash & Equivalents$30.02M
Accounts Receivable$30.92M
Inventory$8.66M
Current Liabilities$65.56M
Long-term Debt$10.00M
Op. Lease Liability$1.17M
Finance Lease$0
Shares Outstanding10.7M

Explore all 149 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$30.02M$30.92M$8.66M$14.26M$65.56M$10.00M$1.17M$0
2025-09-30$32.63M$33.23M$10.10M$12.34M$65.99M$10.45M$1.23M$0
2025-06-30$30.95M$31.16M$11.43M$10.60M$63.06M$10.89M$1.12M$0
2025-03-31$18.17M$35.83M$11.06M$12.04M$70.71M$9.54M$1.10MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-Q 2026-02-03 View
2025-09-30 10-Q 2025-11-13 View
2025-06-30 10-K 2025-09-23 View
2025-03-31 10-Q 2025-05-14 View
2024-12-31 10-Q 2025-02-12 View
2024-09-30 10-Q 2024-11-13 View
2024-06-30 10-K 2024-09-26 View
2024-03-31 10-Q 2024-05-15 View

Community Notes

Loading notes...

Questions

Loading questions...